UBS Lux Equity Fund Biotech USD vs Länsförsäkringar Multistrategi

UBS Lux Equity Fund Biotech USD vs Länsförsäkringar Multistrategi

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Länsförsäkringar Multistrategi

  • Security

    Länsförsäkringar Multistrategi

  • Fee

    1.20%

  • ISIN

    SE0008962914

  • Holdings

    7

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Länsförsäkringar Multistrategi, we have 7 holdings where Schroder Investment Fund Flexible Cat Bond A Acc USD is the largest holding (10.58), followed by SEB FRN Fond A (8.96) and Enter Cross Credit A (7.96).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Länsförsäkringar Multistrategi.

UBS Lux Equity Fund Biotech USD Länsförsäkringar Multistrategi
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Schroder Investment Fund Flexible Cat Bond A Acc USD
UK
10.58 %
2. Moderna Inc
9.21 %
2. SEB FRN Fond A
Sweden
8.96 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Enter Cross Credit A
Sweden
7.96 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. iShares Physical Gold ETC
Ireland
3.21 %
5. AbbVie Inc
USA
4.91 %
5. Rheinmetall AG
Germany
0.66 %
6. Gilead Sciences Inc
USA
4.66 %
6. Roche Holding AG
Switzerland
0.65 %
7. Amgen Inc
USA
4.43 %
7. Iberdrola SA
Spain
0.6 %
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-

The list of fund holdings was last updated on July 25, 2025.